Abstract
Lung cancer (LC) is the leading cause of cancer-related mortality. The five-year relative LC survival varies across Ontario, ranging from 22-32% (2014-2018), with the lowest survival in Southeastern (SE) Ontario. Lung Diagnostic Assessment Program (LDAP) is a rapid assessment clinic that provides specialist care for patients undergoing evaluation for suspected LC. We sought to characterize patient, disease, and system factors, including the influence of LDAP care on survival outcomes, that may contribute to regional differences in LC outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
